Rothblatt Martine A's Form 4 filing
United Therapeutics Corp (UTHR) · filed Aug 26, 2026
- Accession no.
- 0001106578-26-000128
- Filed
- Aug 26, 2026, 4:30 PM ET
- Trade date
- Aug 25, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 7 non-derivative transactions and 1 derivative transaction. Open-market sales total $4.92M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rothblatt Martine ACIK 0001106578 | Director, Officer (Chairperson & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 25, 2026 | Common Stock | MOption exerciseAcquired | +9,500 | $135.42 | +$1,286,490 | 333,943 | Indirect | |
| Aug 25, 2026 | Common Stock | SSaleDisposed | −2,029 | $516.12F3 | −$1,047,204.84 | 331,914 | Indirect | |
| Aug 25, 2026 | Common Stock | SSaleDisposed | −2,332 | $516.95F4 | −$1,205,518.31 | 329,582 | Indirect | |
| Aug 25, 2026 | Common Stock | SSaleDisposed | −2,004 | $518.08F5 | −$1,038,238.13 | 327,578 | Indirect | |
| Aug 25, 2026 | Common Stock | SSaleDisposed | −2,387 | $518.80F6 | −$1,238,375.36 | 325,191 | Indirect | |
| Aug 25, 2026 | Common Stock | SSaleDisposed | −668 | $519.91F7 | −$347,296.94 | 324,523 | Indirect | |
| Aug 25, 2026 | Common Stock | SSaleDisposed | −80 | $520.50F8 | −$41,639.6 | 324,443 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 25, 2026 | Common Stock | MOption exerciseDisposed | −9,500 | $0.00 | $0 | 65,910 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
This transaction was executed in multiple trades at prices ranging from $515.46 to $516.45. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $516.46 to $517.405. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $517.46 to $518.45. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $518.46 to $519.41. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $519.46 to $520.32. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F8
This transaction was executed in multiple trades at prices ranging from $520.47 to $520.52. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.